Brief: Kazia Therapeutics Says Loss For Year Attributable A$24.6 Million
29/08/2022 02:36
Aug 29 (Reuters) - Kazia Therapeutics KZA.AX :
* LOSS FOR YEAR ATTRIBUTABLE A$24.6 MILLION
Source text for Eikon: ID:nASX3qXFDz
Further company coverage: KZA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kazia Therapeutics
See all newsBrief: Kazia Therapeutics Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Brief: Kazia Announces Voluntary Delisting From ASX
Australia's Kazia Therapeutics slumps to 1-yr low on delisting announcement
Brief: Kazia Therapeutics Announces Intention To Voluntarily De-List From ASX
Brief: Kazia Therapeutics Seeks Trading Halt